Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Nicholas A. Forward"'
Autor:
Neil L Berinstein, Gail Klein, Katerina Welsh, Rebecca McClure, Nicholas Allen Forward, Mona Shafey, Anna Nikonova, David MacDonald, Diego Villa, Irwindeep Sandhu, Mohammed A Aljama, Jean-François Larouche
Publikováno v:
Blood. 140:9383-9384
Publikováno v:
Blood. 138:4579-4579
Background: High Grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements (also known as Double-hit lymphoma (DHL)) is an aggressive B cell Non-Hodgkin lymphoma which has recently been recognized by the WHO as a distinct clinical entity fro
Autor:
Philipp Knopf, Manal O. Elnenaei, Marissa Goudie, Andrea Thoni, Darrell White, Daniel Gaston, Nicholas Allen Forward, Samuel D. Cutler, Julie Wagner
Publikováno v:
Blood. 136:37-38
Introduction: Multiple Myeloma (MM) is the second most common hematological malignancy in North America. It is characterized by invasion of the bone marrow by malignant plasma cells. This malignancy presents with a broad range of primary genomic lesi
Autor:
Mohamed Abou El Hassan, Wenda L. Greer, Nicholas A. Forward, Clinton J. V. Campbell, Samuel D. Cutler, Philipp Knopf, Manal O. Elnenaei, Julie Wagner, Daniel Gaston, Darrell White, Keaton Sinclair, Stephen Couban, Marissa Goudie
Publikováno v:
Clinical genetics. 96(2)
Multiple myeloma (MM) is an incurable hematological malignancy that relies on cytogenetic determination of copy number abnormalities (CNAs) for prognosis and management. Low-depth whole genome sequencing (LD-WGS) is a cost-effective alternative to ta
Autor:
Irina Amitai, Gail Klein, Yogesh Bramhecha, Isabelle Bence-Bruckler, Iran Rashedi, Douglas A. Stewart, Joy Mangel, Rebekah Conlon, Pierre Laneuville, Neil L. Berinstein, Nancy Pennell, Kim Roos, Nicholas Allen Forward
Publikováno v:
Blood. 136:16-16
Background: Recurrent/refractory (r/r) DLBCL presents a major treatment challenge, especially in the setting of patients who are ineligible for, or relapsing after, potentially curative treatments such as autologous stem cell transplant (ASCT) and ch
Autor:
Liam Smyth, Nicholas Allen Forward, Gail Klein, Isabelle Bence-Bruckler, Nancy Pennell, Pierre Laneuville, Douglas A. Stewart, Kim Roos, Neil L. Berinstein
Publikováno v:
Blood. 134:3236-3236
Introduction: Recurrent/refractory diffuse large B cell lymphoma (DLBCL) remains an area of unmet clinical need. Although autologous stem cell transplant (ASCT), and more recently chimeric antigen receptor (CAR) T cell therapy, have made a significan
Autor:
Nicholas A. Forward, Adam J. MacNeil, Tong-Jun Lin, Svetlana O. Carrigan, David W. Hoskin, Robert D. Junkins, Jason N. Berman, Jin-Tian Tang, Yongjun Yang
Publikováno v:
The American Journal of Pathology. 179:1199-1210
The presence of eosinophils in the lung is often regarded as a defining feature of asthma. On allergen stimulation, numbers of eosinophils and their progenitors are increased in both the bone marrow and lungs. Eosinophil progenitors provide an ongoin
Autor:
Nicholas A. Forward, David W. Hoskin, David M. Conrad, Carolyn D. Doucette, Melanie R. Power Coombs, Suzanne J. Furlong, Tong-Jun Lin
Publikováno v:
Biochemical and Biophysical Research Communications. 407:801-806
Curcumin (diferulomethane) is the principal curcuminoid in the spice tumeric and a potent inhibitor of activation-induced T-lymphocyte proliferation; however, the molecular basis of this immunosuppressive effect has not been well studied. Here we sho
Autor:
Yongjun Yang, Nicholas A. Forward, Svetlana O. Carrigan, Brent Johnston, Thomas B. Issekutz, David W. Hoskin, Tong-Jun Lin
Publikováno v:
Immunobiology. 214:211-222
Pseudomonas aeruginosa is a common cause of lung infection in immune compromised individuals. Studies in humans and mice have demonstrated that P. aeruginosa lung infection is associated with a predominant Th2 immune response, whereas Th1 responses a
Autor:
Melanie R. Power Coombs, David M. Conrad, David W. Hoskin, Nicholas A. Forward, Suzanne J. Furlong
Publikováno v:
Immunology and cell biology. 90(2)
Thy-1 (CD90) on mouse T cells has been reported to have both T-cell activating and regulatory roles. In this study, we show that monoclonal antibody (mAb)-mediated crosslinking of Thy-1 on CD4(+) mouse T-cells-induced regulatory T (T(reg)) cells that